A recent study discovered significant levels of metals in the blood and urine of marijuana users, indicating marijuana as a possible unrecognized source of lead and cadmium exposure. This research, among the first to link self-reported marijuana use with internal metal exposure, raises concerns about public health, especially as marijuana consumption rises and federal regulations remain inconsistent.
A Columbia University study found high metal levels in marijuana users’ blood and urine, highlighting potential health risks and emphasizing the need for consistent regulations.
Research recently conducted at Columbia University Mailman School of Public Health detected significant levels of metals in the blood and urine among marijuana users. The results suggest that marijuana may be an important and under-recognized source of lead and cadmium exposure.
This is among the first studies to report biomarker metal levels among marijuana users and most likely the largest study to date, that links self-reported marijuana use to internal measures of metal exposure, rather than just looking at metal levels in the cannabis plant. The results were published on August 30 in the journal Environmental Health Perspectives.
Key Findings
Measurements reported by participants for exclusive marijuana use compared to nonmarijuana-tobacco had significantly higher lead levels in blood (1.27 ug/dL) and urine (1.21 ug/g creatinine).
“Because the cannabis plant is a known scavenger of metals, we had hypothesized that individuals who use marijuana will have higher metal biomarker levels compared to those who do not use,” said Katelyn McGraw, postdoctoral researcher in Columbia Public Health’s Department of Environmental Health Sciences, and the first author. “Our results therefore indicate marijuana is a source of cadmium and lead exposure.”
Research Methodology
The researchers combined data from the National Health and Nutrition Examination Survey for the years 2005-2018). Led by the National Center for Health Statistics (NCHS) at the CDC, NCHS NHANES is a biannual program of studies designed to assess the health and nutritional status of adults and children in the U.S.
McGraw and colleagues classified the 7,254 survey participants by use: non-marijuana/non-tobacco, exclusive marijuana, exclusive tobacco, and dual marijuana and tobacco use. Five metals were measured in the blood and 16 in urine.
The researchers used four NHANES variables to define exclusive marijuana and tobacco use: current cigarette smoking, serum cotinine levels, self-reported ever marijuana use, and recent marijuana use. Exclusive tobacco use was defined as individuals who either answered yes to ‘do you now smoke cigarettes, or if individuals had a serum cotinine level >10ng/mL.
Marijuana’s Prevalence and Regulation
Marijuana is the third most commonly used drug in the world behind tobacco and alcohol. As of 2022, 21 states and Washington D.C., covering more than 50 percent of the U.S. population, have legalized recreational use of marijuana; and medical marijuana is legal in 38 states and Washington D.C. However, because marijuana is still illegal at the federal level, regulation of contaminants in all cannabis-containing products remains piecemeal and there has been no guidance from federal regulatory agencies like the FDA or EPA. As of 2019, 48.2 million people, or 18 percent of Americans, report using marijuana at least once in the last year.
While 28 states regulate inorganic arsenic, cadmium, lead, and total mercury concentrations in marijuana products, regulation limits vary by metal and by state.
“Going forward, research on cannabis use and cannabis contaminants, particularly metals, should be conducted to address public health concerns related to the growing number of cannabis users,” said Tiffany R. Sanchez, PhD, assistant professor of environmental health sciences at Columbia Public Health, and senior author.
Reference: “Blood and Urinary Metal Levels among Exclusive Marijuana Users in NHANES (2005–2018)” by Katlyn E. McGraw, Anne E. Nigra, Joshua Klett, Marisa Sobel, Elizabeth C. Oelsner, Ana Navas-Acien, Xin Hu and Tiffany R. Sanchez, 30 August 2023, Environmental Health Perspectives.
DOI: 10.1289/EHP12074
Co-authors are Anne E. Nigra, Joshua Klett, Marisa Sobel, and Ana Navas-Acien, Columbia Public Health; Elizabeth C. Oelsner, Columbia University Irving Medical Center; and Xin Hu, Emory University School of Medicine.
The study was supported by the National Institutes of Health (NIH) National Institute of Environmental Health grants P30ES009089 and T32ES007322.
